论文部分内容阅读
目的:探讨喜炎平注射液佐治儿童病毒性肺炎的疗效。方法:选择2011年1月～2012年1月我院儿科住院的160例病毒性肺炎患儿。入院24小时内检测呼吸道常见7种病毒,随机分为2组。在常规治疗的基础上,治疗组加用喜炎平注射液0.2～0.4ml/kg.d,对照组加用利巴韦林10mg/kg.d,连用5天。结果:160例患儿病毒检测阳性率为77.5%(124/160),其中治疗组为76.25%,对照组为78.75%,差异无统计学意义(P>0.05)。治疗组退热、咳喘改善、肺部罗音消失时间及住院天数等均短于对照组,差异有统计学意义(P均<0.05)。住院总费用2组比较差异无统计学意义(P>0.05)。结论:喜炎平佐治儿童病毒性肺炎疗效好,副作用少,且不增加患者经济费用,值得临床推广使用。
Objective: To investigate the effect of Xiyanping injection in treating children with viral pneumonia. Methods: From January 2011 to January 2012, 160 children with viral pneumonia admitted to our pediatric department were selected. Within 24 hours of admission, 7 common respiratory viruses were detected and randomly divided into 2 groups. On the basis of conventional treatment, the treatment group plus Xiyanping injection 0.2 ~ 0.4ml / kg.d, the control group plus ribavirin 10mg / kg.d, once every 5 days. Results: The positive rate of virus detection in 160 children was 77.5% (124/160), of which 76.25% in treatment group and 78.75% in control group, the difference was not statistically significant (P> 0.05). The treatment group fever, cough and asthma improvement, pulmonary rales disappear time and hospitalization days were shorter than the control group, the difference was statistically significant (P all <0.05). There was no significant difference in the total cost of hospitalization between the two groups (P> 0.05). Conclusion: Xiyanping adjuvant treatment of children with viral pneumonia curative effect, less side effects, and does not increase the economic costs of patients, it is worth promoting the use of the clinic.